Canadian cannabis company Aurora Cannabis (Nasdaq: ACB) reported that its fourth-quarter net revenue for medical cannabis increased 4% year-over-year to $36.6 million, while adult-use cannabis revenue fell 35% year-over-year to $12.6 million. Sequentially, sales of adult-use cannabis increased 22% from the third quarter, primarily due to sales from its “profitable acquisition” of Thrive Cannabis. C21 […]